Bone

GREENRIDGE FARM ANNOUNCES REBRAND AND DEBUTS AS GREENRIDGE

Retrieved on: 
Wednesday, August 30, 2023
Honey, Bone, Food, Nitrate, Natural, Blog, Nitrite, Phosphate, ELK, National Association of Convenience Stores, Convenience, Growth, MSG, National Association, Health, Sodium, Condiment, Grocery store, Baking, Online shopping, Chicago metropolitan area, Head cheese

ELK GROVE VILLAGE, Ill., Aug. 30, 2023 /PRNewswire/ -- Greenridge Farm, the Chicago-based, family-owned brand specializing in all-natural uncured deli meats, meat sticks, sausages, cheeses, and condiments is officially rebranding to Greenridge. The company debuted its updated name, website, and logo and is rolling out new packaging on all products at consumer retailers and food service partners this month.

Key Points: 
  • ELK GROVE VILLAGE, Ill., Aug. 30, 2023 /PRNewswire/ -- Greenridge Farm, the Chicago-based, family-owned brand specializing in all-natural uncured deli meats, meat sticks, sausages, cheeses, and condiments is officially rebranding to Greenridge.
  • Greenridge Farm Announces Rebrand and Debuts as Greenridge, offering all-natural deli meats, sausages, and snack sticks.
  • The Greenridge rebrand better reflects the company's ethos of delivering high-quality meats and cheeses, emphasizing their all-natural, clean-label offerings.
  • For more information, to shop Greenridge products, and find your nearest Greenridge retailer, please visit www.greenridgenaturals.com

City of Hope is the first cancer center in Southern California to offer patients novel targeted radiotherapy

Retrieved on: 
Monday, August 28, 2023
City of Hope, Bone, Radiation, Gastrointestinal tract, Neoplasm, Bone marrow, Cancer, PET, Breast, Research, Immunotherapy, Lung, Radiation therapy, Movement, Reflection, City, Patient, Risk, Blood, Medicine, Biology, Metastasis, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Society, Food, Disease, FDG, Medical imaging, Hope

LOS ANGELES, Aug. 28, 2023 /PRNewswire/ -- City of Hope, one of the largest cancer research and treatment organizations in the United States, is the first health system in Southern California to offer patients diagnosed with primary or metastatic lung and bone cancer a new form of radiotherapy that can detect and treat multiple tumors in real time using precision targeting.

Key Points: 
  • The RefleXion® X1 system delivers SCINTIXTM biology-guided radiotherapy, a leading-edge treatment that combines positron emission tomography (PET) with targeted radiation therapy.
  • As part of their treatment regimen, between half and two-thirds of cancer patients receive radiotherapy, according to the American Society for Therapeutic Radiology and Oncology.
  • Through their efforts, City of Hope researchers hope to bring the world closer to the ability to deliver personalized radiotherapy treatment that is specific to a particular cancer.
  • City of Hope is a minority investor in RefleXion, and currently holds less than 1% of the company's outstanding shares.

Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit

Retrieved on: 
Wednesday, August 23, 2023
University of Texas Southwestern Medical Center, Senior, American Society of Clinical Oncology, Health equity, Associate, Teaching hospital, NCCN, American College of Physicians, Cancer, Patient, American College, Chair, The College of New Jersey, BS, FRCP, Physician, FACP, Policy, National Comprehensive Cancer Network, Research, Organization, Panel, Mount Sinai Medical Center, Baylor College of Medicine, Caregiver, Abstract, Harold, Associate professor, Capitol Hill, Medicine, ORP, Journal of the National Comprehensive Cancer Network, New Jersey Medical School, Equitable, Regius Professor, Bone, ASCO, Society, Medical device, Nursing, MD

PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- Today the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading academic cancer centers—announced Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer (CEO). Dr. Denlinger—who is currently NCCN's Senior Vice President, Chief Scientific Officer—is being promoted to lead the global guidelines organization following a national search to replace the retiring longtime CEO, Robert W. Carlson, MD.

Key Points: 
  • PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- Today the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading academic cancer centers—announced Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer (CEO).
  • Crystal S. Denlinger, MD, FACP, to lead the National Comprehensive Cancer Network (NCCN), a global cancer nonprofit.
  • She will also lead and oversee programs advancing global collaborations, new oncology research, peer-reviewed publication, patient information, and cancer policy.
  • NCCN's recognition and influence relating to national and global cancer care policy also increased dramatically during his tenure."

Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit

Retrieved on: 
Wednesday, August 23, 2023
University of Texas Southwestern Medical Center, Senior, American Society of Clinical Oncology, Health equity, Associate, Teaching hospital, NCCN, American College of Physicians, Cancer, Patient, American College, Chair, The College of New Jersey, BS, FRCP, Physician, FACP, Policy, National Comprehensive Cancer Network, Research, Organization, Panel, Mount Sinai Medical Center, Baylor College of Medicine, Caregiver, Abstract, Harold, Associate professor, Capitol Hill, Medicine, ORP, Journal of the National Comprehensive Cancer Network, New Jersey Medical School, Equitable, Regius Professor, Bone, ASCO, Society, Medical device, Nursing, MD

PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- Today the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading academic cancer centers—announced Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer (CEO). Dr. Denlinger—who is currently NCCN's Senior Vice President, Chief Scientific Officer—is being promoted to lead the global guidelines organization following a national search to replace the retiring longtime CEO, Robert W. Carlson, MD.

Key Points: 
  • PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- Today the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading academic cancer centers—announced Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer (CEO).
  • Dr. Denlinger has a long history of global cancer care leadership with NCCN and beyond.
  • She will also lead and oversee programs advancing global collaborations, new oncology research, peer-reviewed publication, patient information, and cancer policy.
  • NCCN's recognition and influence relating to national and global cancer care policy also increased dramatically during his tenure."

The Shriners Hospitals for Children - Canada Research Centre celebrates half a century of existence

Retrieved on: 
Thursday, August 17, 2023
Dentistry, Parent, Teaching, Anxiety, Research institute, Quality of life, Bone, Collagen, type I, alpha 1, OC, Research, Medicine, Bone disease, Health, Doctor of Philosophy, Government, Pain, DSM-IV codes, International Clinical Research Center, Metabolic bone disease, Student, MD, Physician, Shriners Hospitals for Children, McGill University, Virtual reality, Knowledge, Diagnosis, McGill University Health Centre, X-linked hypophosphatemia, Nursing research, MRC Human Genetics Unit, Shriners, Hormone replacement therapy, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Nursing, Child

So research into mineralized tissue has always been a strength in Quebec," explains Professor René St-Arnaud, PhD, Director of the Research Center.

Key Points: 
  • So research into mineralized tissue has always been a strength in Quebec," explains Professor René St-Arnaud, PhD, Director of the Research Center.
  • In 1973, following the integration of Shriners Hospitals for Children – Canada into the Quebec health care network, Shriners Children’s management, with the approval of the provincial government, created the first Research Centre within its hospital network.
  • The Shriners Hospital for Children - Canada Research Centre is constantly developing new ways to care for children.
  • To mark this 50th anniversary at Shriners Hospital for Children – Canada, Dr. St-Arnaud hosted a scientific seminar yesterday featuring a number of prestigious speakers.

QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data

Retrieved on: 
Wednesday, August 16, 2023
CT, Radiation, Bone, Neoplasm, PSMA, PSMA5, Bone metastasis, Survival, RECIST, Cancer, OTCQB, Spine, Breast, Prostate, Radiopharmaceutical, Lung, Incidence, Patient, Physician, Prostate cancer, Diagnosis, QSAM, Lung cancer, FDA, Letter, Ecosystem, Environment, Social media, Safety, Breast cancer, Medical imaging, Pharmaceutical industry, Female, SUV, Q4

In patients one and three, we saw no progression of tumor size at the four month follow-up.

Key Points: 
  • In patients one and three, we saw no progression of tumor size at the four month follow-up.
  • We must remind our shareholders, however, that these results are very early and are not necessarily indicative of future results in our trials.
  • Further, this summary is not a formal read-out of data, but rather, a preliminary analysis of our Cohort 1 findings.
  • Ultimately, however, our primary mission is to help the hundreds of thousands of adults and children each year suffering from bone cancer.

TEGNA Stations Receive Ten National 2023 Edward R. Murrow Awards

Retrieved on: 
Thursday, August 17, 2023
Digital Marketing, Other Communications, Public Relations, Investor Relations, TV and Radio, Marketing, Advertising, Communications, Entertainment, Dark, Boyd Huppert, Supreme Court of Ohio, KARE, Journalism, Bone, RTDNA, Infotainment, Edward R. Murrow Award (Radio Television Digital News Association), The Center for Investigative Reporting, Camp Fire (2018), EVP, TGNA, TEGNA, Woman, Dark side, PG, GA, History, ABC10, Ohio Supreme Court elections, Marshall Fire, WTIC, WXIA, Sadness, 9News, Organization, Disaster, Cedar Point, WFAA, IA Financial Group, Edward, Love, WBNS, Child, KXTV, KUSA, Podcast, Weather, Digital, PG&E, Cedar Fair, Death, Safety, News, NYSE, WKYC, 33rd News & Documentary Emmy Awards, Campfire, Mobile phone, Film industry, Ethics

TEGNA Inc. (NYSE: TGNA) today announced its stations have received ten 2023 National Edward R. Murrow Awards for excellence in broadcast journalism, more than any other station group.

Key Points: 
  • TEGNA Inc. (NYSE: TGNA) today announced its stations have received ten 2023 National Edward R. Murrow Awards for excellence in broadcast journalism, more than any other station group.
  • The Edward R. Murrow Awards are sponsored by the Radio Television Digital News Association (RTDNA) and honor outstanding achievements in broadcast and digital journalism.
  • “Congratulations to all our stations that were recognized for their work.”
    The prestigious Murrow Awards “recognize local and national news stories that uphold the RTDNA Code of Ethics, demonstrate technical expertise and exemplify the importance and impact of journalism as a service to the community.”
    TEGNA stations’ National Edward R. Murrow Award recipients are:
    WFAA (Dallas, TX): Overall Excellence, Large Market Television.
  • For 2023, TEGNA stations were also honored with 84 Regional Edward R. Murrow Awards .

Degen Announces Release of Rocketcoin

Retrieved on: 
Monday, May 22, 2023
Universe, Ethereum, Meme coin, Bone, Rocket (Marvel Cinematic Universe), ETH, Marketing, Survival, Uniswap, Degen, Samsung DeX, CEX, Raccoon, Euphoria, Ecosystem, Guardians of the Galaxy, Rocket Raccoon, LP, Marvel Cinematic Universe, Environment, Cryptocurrency, Galaxy

In its initial release, the Degen Rocket Racoon project has already scaled 80% liquidity with the remaining 20% left for CEX reserve allocation, marketing and partnerships and airdrops.

Key Points: 
  • In its initial release, the Degen Rocket Racoon project has already scaled 80% liquidity with the remaining 20% left for CEX reserve allocation, marketing and partnerships and airdrops.
  • The Degen Rocket Raccoon team for that reason has made specific plans for an equal entry for all despite their capabilities to become a part of the growing Degen Rocket Raccoon ecosystem.
  • Functionally, Degen Rocket Racoon offers equal opportunities for participation in token sales and facilitates feeless trading on the popular Uniswap platform.
  • If you have yet to embark on the exhilarating adventure of Degen Rocket Racoon and yearn.

AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE Randomized, Controlled Trial

Retrieved on: 
Tuesday, August 8, 2023
Science, Biotechnology, Research, Surgery, Health, Medical Devices, Health Technology, Clinical Trials, Geneva University Hospitals, Journal of Orthopaedic Trauma, Osteoporosis, Senior, Internal medicine, Hip, Boston Medical Center, Woman, Bone disease, Trial of the century, Bone, Organization, Andrew Kerr (festival co-founder), Local, Patient, Fracture, Risk, Disease, Mortality, Trauma, Dentistry, Medical device

The Company has activated more than 30 study sites across Japan, Germany, Spain, France, Italy, the UK, the Netherlands and Austria.

Key Points: 
  • The Company has activated more than 30 study sites across Japan, Germany, Spain, France, Italy, the UK, the Netherlands and Austria.
  • RESTORE is expected to include more than 50 study sites and enroll at least 650 patients.
  • “The initiation of RESTORE and the enrollment of the 150th patient is a major milestone for the Company,” explained James Pilachowski, Senior Vice President of Hip Program.
  • I look forward to reviewing the data generated by RESTORE with other clinicians and organizations committed to addressing secondary hip fracture risk.”

SPARK™ CLEAR ALIGNERS ANNOUNCES KEY CLINICAL UPDATES & DOCTOR-DRIVEN INNOVATIONS IN RELEASE 14

Retrieved on: 
Tuesday, August 8, 2023
Orthodontics, R14, Workflow, Internet, Firefox, IOS, Google Chrome, Microsoft Edge, Education minister, Bone, XR, Opera, Electric motor, Video game, Spark, Danaher Corporation

BREA, Calif., Aug. 8, 2023 /PRNewswire/ -- Ormco Corporation announces the highly anticipated Spark Clear Aligners Release 14.  Release 14 continues Spark's philosophy of giving orthodontists control and flexibility. The Spark Aligner System is already an open platform that accepts scans from all major intraoral scanners. Now with Release 14, doctors will have even greater flexibility with the introduction of Spark Approver Web and seamless DEXIS™ IOS integration, along with exciting clinical and workflow updates.   

Key Points: 
  • BREA, Calif., Aug. 8, 2023 /PRNewswire/ -- Ormco Corporation announces the highly anticipated Spark Clear Aligners Release 14.
  • Now with Release 14, doctors will have even greater flexibility with the introduction of Spark Approver Web and seamless DEXIS™ IOS integration, along with exciting clinical and workflow updates.
  • Ormco also recently launched new clinical updates and user experience features, including:
    Spark's Integrated Hooks now include three size choices in retention attachments.
  • For more information on Spark Release 14 and other recent improvements, please visit https://ormco.com/en-us/spark-r14-update or contact your Sales Representative.